FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W4321003911> ?p ?o ?g. }

• W4321003911 abstract "Abstract Novel adjuvants are highly desired to improve immune responses of SARS‐CoV‐2 vaccines. This work reports the potential of the stimulator of interferon genes (STING) agonist adjuvant, the cyclic di‐adenosine monophosphate (c‐di‐AMP), in a SARS‐CoV‐2 vaccine based on the receptor binding domain (RBD). Here, mice immunized with two doses of monomeric RBD adjuvanted with c‐di‐AMP intramuscularly were found to exhibit stronger immune responses compared to mice vaccinated with RBD adjuvanted with aluminum hydroxide (Al(OH) 3 ) or without adjuvant. After two immunizations, consistent enhancements in the magnitude of RBD‐specific immunoglobulin G (IgG) antibody response were observed by RBD + c‐di‐AMP (mean: 15360) compared to RBD + Al(OH) 3 (mean: 3280) and RBD alone (n.d.). Analysis of IgG subtypes indicated a predominantly Th1‐biased immune response (IgG2c, mean: 14480; IgG2b, mean: 1040, IgG1, mean: 470) in mice vaccinated with RBD + c‐di‐AMP compared to a Th2‐biased response in those vaccinated with RBD + Al(OH) 3 (IgG2c, mean: 60; IgG2b: n.d.; IgG1, mean: 16660). In addition, the RBD + c‐di‐AMP group showed better neutralizing antibody responses as determined by pseudovirus neutralization assay and by plaque reduction neutralization assay with SARS‐CoV‐2 wild type. Moreover, the RBD + c‐di‐AMP vaccine promoted interferon‐γ secretion of spleen cell cultures after RBD stimulation. Furthermore, evaluation of IgG‐antibody titers in aged mice showed that di‐AMP was able to improve RBD‐immunogenicity at old age after 3 doses (mean: 4000). These data suggest that c‐di‐AMP improves immune responses of a SARS‐CoV‐2 vaccine based on RBD, and would be considered a promising option for future COVID‐19 vaccines." @default.
• W4321003911 created "2023-02-17" @default.
• W4321003911 creator A5011337084 @default.
• W4321003911 creator A5036283151 @default.
• W4321003911 creator A5043559906 @default.
• W4321003911 creator A5047100943 @default.
• W4321003911 creator A5050081158 @default.
• W4321003911 creator A5051317374 @default.
• W4321003911 creator A5055379218 @default.
• W4321003911 creator A5065657680 @default.
• W4321003911 creator A5069606041 @default.
• W4321003911 creator A5071188500 @default.
• W4321003911 creator A5084826480 @default.
• W4321003911 creator A5089667784 @default.
• W4321003911 date "2023-02-01" @default.
• W4321003911 modified "2023-10-06" @default.
• W4321003911 title "Receptor‐binding domain‐based SARS‐CoV‐2 vaccine adjuvanted with cyclic di‐adenosine monophosphate enhances humoral and cellular immunity in mice" @default.
• W4321003911 cites W1990735603 @default.
• W4321003911 cites W2017103869 @default.
• W4321003911 cites W2082399161 @default.
• W4321003911 cites W2088139849 @default.
• W4321003911 cites W2538483139 @default.
• W4321003911 cites W2601123794 @default.
• W4321003911 cites W2916082845 @default.
• W4321003911 cites W2959930806 @default.
• W4321003911 cites W3004318991 @default.
• W4321003911 cites W3025320502 @default.
• W4321003911 cites W3029682964 @default.
• W4321003911 cites W3034680516 @default.
• W4321003911 cites W3037923073 @default.
• W4321003911 cites W3040017923 @default.
• W4321003911 cites W3042183476 @default.
• W4321003911 cites W3082438395 @default.
• W4321003911 cites W3087903445 @default.
• W4321003911 cites W3091777569 @default.
• W4321003911 cites W3121008609 @default.
• W4321003911 cites W3130193275 @default.
• W4321003911 cites W3157022736 @default.
• W4321003911 cites W3157560587 @default.
• W4321003911 cites W3157764873 @default.
• W4321003911 cites W3169050798 @default.
• W4321003911 cites W3169082905 @default.
• W4321003911 cites W3178772652 @default.
• W4321003911 cites W3179071715 @default.
• W4321003911 cites W3179238217 @default.
• W4321003911 cites W3195854721 @default.
• W4321003911 cites W3209647419 @default.
• W4321003911 cites W4205855819 @default.
• W4321003911 cites W4206495469 @default.
• W4321003911 cites W4220782453 @default.
• W4321003911 cites W4220850641 @default.
• W4321003911 cites W4221042703 @default.
• W4321003911 cites W4250333371 @default.
• W4321003911 cites W4281670396 @default.
• W4321003911 doi "https://doi.org/10.1002/jmv.28584" @default.
• W4321003911 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/36794675" @default.
• W4321003911 hasPublicationYear "2023" @default.
• W4321003911 type Work @default.
• W4321003911 citedByCount "1" @default.
• W4321003911 countsByYear W43210039112023 @default.
• W4321003911 crossrefType "journal-article" @default.
• W4321003911 hasAuthorship W4321003911A5011337084 @default.
• W4321003911 hasAuthorship W4321003911A5036283151 @default.
• W4321003911 hasAuthorship W4321003911A5043559906 @default.
• W4321003911 hasAuthorship W4321003911A5047100943 @default.
• W4321003911 hasAuthorship W4321003911A5050081158 @default.
• W4321003911 hasAuthorship W4321003911A5051317374 @default.
• W4321003911 hasAuthorship W4321003911A5055379218 @default.
• W4321003911 hasAuthorship W4321003911A5065657680 @default.
• W4321003911 hasAuthorship W4321003911A5069606041 @default.
• W4321003911 hasAuthorship W4321003911A5071188500 @default.
• W4321003911 hasAuthorship W4321003911A5084826480 @default.
• W4321003911 hasAuthorship W4321003911A5089667784 @default.
• W4321003911 hasConcept C14086860 @default.
• W4321003911 hasConcept C153911025 @default.
• W4321003911 hasConcept C159047783 @default.
• W4321003911 hasConcept C159654299 @default.
• W4321003911 hasConcept C185592680 @default.
• W4321003911 hasConcept C203014093 @default.
• W4321003911 hasConcept C2776178377 @default.
• W4321003911 hasConcept C2776548049 @default.
• W4321003911 hasConcept C2777863537 @default.
• W4321003911 hasConcept C2779261636 @default.
• W4321003911 hasConcept C2780868878 @default.
• W4321003911 hasConcept C86803240 @default.
• W4321003911 hasConcept C8891405 @default.
• W4321003911 hasConceptScore W4321003911C14086860 @default.
• W4321003911 hasConceptScore W4321003911C153911025 @default.
• W4321003911 hasConceptScore W4321003911C159047783 @default.
• W4321003911 hasConceptScore W4321003911C159654299 @default.
• W4321003911 hasConceptScore W4321003911C185592680 @default.
• W4321003911 hasConceptScore W4321003911C203014093 @default.
• W4321003911 hasConceptScore W4321003911C2776178377 @default.
• W4321003911 hasConceptScore W4321003911C2776548049 @default.
• W4321003911 hasConceptScore W4321003911C2777863537 @default.
• W4321003911 hasConceptScore W4321003911C2779261636 @default.
• W4321003911 hasConceptScore W4321003911C2780868878 @default.
• W4321003911 hasConceptScore W4321003911C86803240 @default.
• W4321003911 hasConceptScore W4321003911C8891405 @default.
• W4321003911 hasIssue "2" @default.

• next